GPR15L (71-81) (Human) [3755]
GPR15L (71-81) (Human)
| SMILES |
CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C |
| InChIKey |
NLEQDIXNHJSWHA-UPULOONWSA-N |
| Sequence |
LWVVPGALPQV |
| HELM |
PEPTIDE1{L.W.V.V.P.G.A.L.P.Q.V}$$$$ |
Chemical Properties
| Hydrogen bond acceptors |
13 |
| Hydrogen bond donors |
12 |
| Rotatable bonds |
31 |
| Log P |
-0.040 |
| Molecular weight (Da) |
1177.7 |
| Stereochemistry info |
unspecified |
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.